Recommendations for the Use of Multimodal Monitoring in the Neurointensive Care Unit
Overview
Affiliations
Purpose Of Review: Multimodal monitoring (MMM) is routinely applied in neurointensive care. Unfortunately, there is no robust evidence on which MMM-derived physiologic variables are the most clinically relevant, how and when they should be monitored, and whether MMM impacts outcome. The complexity is even higher because once the data are continuously collected, interpretation and integration of these complex physiologic events into targeted individualized care is still embryonic.
Recent Findings: Recent clinical investigation mainly focused on intracranial pressure, perfusion of the brain, and oxygen availability along with electrophysiology. Moreover, a series of articles reviewing the available evidence on all the MMM tools, giving practical recommendations for bedside MMM, has been published, along with other consensus documents on the role of neuromonitoring and electroencephalography in this setting.
Summary: MMM allows comprehensive exploration of the complex pathophysiology of acute brain damage and, depending on the different configuration of the pathological condition we are treating, the application of targeted individualized care. Unfortunately, we still lack robust evidence on how to better integrate MMM-derived information at the bedside to improve patient management. Advanced informatics is promising and may provide us a supportive tool to interpret physiologic events and guide pathophysiological-based therapeutic decisions.
van Twist E, Robles T, Formsma B, Ketharanathan N, Hunfeld M, Buysse C J Clin Monit Comput. 2024; .
PMID: 39702837 DOI: 10.1007/s10877-024-01248-w.
Adapting NeuroVanguard to real-world challenges.
Giglio A, Pino M, Ferre A, Reccius A Crit Care. 2024; 28(1):137.
PMID: 38654362 PMC: 11040980. DOI: 10.1186/s13054-024-04916-0.
"NeuroVanguard": a contemporary strategy in neuromonitoring for severe adult brain injury patients.
Rodriguez E, Zaccarelli M, Sterchele E, Taccone F Crit Care. 2024; 28(1):104.
PMID: 38561829 PMC: 10985991. DOI: 10.1186/s13054-024-04893-4.
Shah I, Chen P, Tran D, Chen J Surg Neurol Int. 2023; 14:395.
PMID: 38053714 PMC: 10695458. DOI: 10.25259/SNI_679_2023.
Barrit S, El Hadwe S, Al Barajraji M, Torcida N, Gouvea Bogossian E, Andre J Neurocrit Care. 2023; 40(3):1182-1192.
PMID: 37991675 DOI: 10.1007/s12028-023-01885-0.